KeyBioscience AG: Clinical Trials

1 trial sponsored by KeyBioscience AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow KeyBioscience AG: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
Daily injection of KBP/placebo for up to 28 days - Type II Diabetes Mellitus
Phase 1TerminatedKeyBioscience AG252018-04-172020-09-03

Conditions studied

Diabetes Mellitus, Type 2 (1)

Countries

Germany (1)

Top investigators

Tim Heise, MD (1)